Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Versari

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|June 23, 2007
The importance of reendothelialization after arterial injuryD Versari, L O Lerman, A Lerman
Current Pharmaceutical Design|October 8, 2003
Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategiesS Taddei, L Ghiadoni, A Virdis, et al.
Current Pharmaceutical Design|August 5, 2008
Endothelial function assessment in complicated hypertensionA Virdis, L Ghiadoni, D Versari, et al.
Current Pharmaceutical Design|July 20, 2005
Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?A Virdis, L Ghiadoni, D Versari, et al.
Atherosclerosis|January 9, 2009
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patientsD Versari, A Virdis, L Ghiadoni, et al.
Current Pharmaceutical Design|April 10, 2009
Obesity in the childhood: a link to adult hypertensionA Virdis, L Ghiadoni, S Masi, et al.
Reumatismo|October 3, 2006
[Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD]C Tani, M Mosca, A d'Ascanio, et al.
Atherosclerosis|April 17, 2009
Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesisM Gössl, D Versari, L O Lerman, et al.
Diabetologia|April 19, 2011
Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetesR M Bruno, E Daghini, L Landini, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|June 23, 2007
The importance of reendothelialization after arterial injuryD Versari, L O Lerman, A Lerman
Current Pharmaceutical Design|October 8, 2003
Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategiesS Taddei, L Ghiadoni, A Virdis, et al.
Current Pharmaceutical Design|August 5, 2008
Endothelial function assessment in complicated hypertensionA Virdis, L Ghiadoni, D Versari, et al.
Current Pharmaceutical Design|July 20, 2005
Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?A Virdis, L Ghiadoni, D Versari, et al.
Atherosclerosis|January 9, 2009
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patientsD Versari, A Virdis, L Ghiadoni, et al.
Current Pharmaceutical Design|April 10, 2009
Obesity in the childhood: a link to adult hypertensionA Virdis, L Ghiadoni, S Masi, et al.
Reumatismo|October 3, 2006
[Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD]C Tani, M Mosca, A d'Ascanio, et al.
Atherosclerosis|April 17, 2009
Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesisM Gössl, D Versari, L O Lerman, et al.
Diabetologia|April 19, 2011
Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetesR M Bruno, E Daghini, L Landini, et al.
Pageof 1